fluticasone

Known as: Fluticasonum, Fluticasone [Chemical/Ingredient], Fluticasona 
A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND & AIMS We evaluated the effect of aerosolized fluticasone therapy on symptomatic dysphagia and histologic eosinophilia… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Both gastroesophageal reflux disease and allergy/atopy have been implicated in the pathogenesis of eosinophilic esophagitis (EoE… (More)
  • table 1
  • figure 3
  • figure 1
  • figure 4
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND & AIMS Although eosinophilic esophagitis is recognized increasingly, outcome data guiding therapy are limited. We… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
RATIONALE Small studies have suggested that inhaled corticosteroids can suppress systemic inflammation in chronic obstructive… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART) improves asthma control compared with fixed… (More)
Is this relevant?
Review
2007
Review
2007
Asthma is the leading chronic disease among children in most industrialized countries. However, the evidence base on specific… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND International guidelines for the treatment of asthma recommend adjusting the dose of inhaled corticosteroids on the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Patients with severe asthma are often inadequately controlled on existing anti-asthma therapy, constituting an unmet… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Inhaled long-acting beta2 agonists improve lung function and health status in symptomatic chronic obstructive… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2002
Review
2002
The addition of an inhaled long-acting beta2-agonist (LABA) to an inhaled corticosteroid (ICS) gives optimal control of asthma in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?